Verastem, Inc. Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months
Verastem, Inc. (VSTM) had Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months of $16.13 million as of 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Debt and Equity Securities › Debt Securities, Available-for-Sale, Unrealized Loss Position
us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months · last filed 2026-05-07
- 2026-03-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $16.13M.
- 2023-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $8.90M.
- 2022-12-31: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $5.96M; Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months as first filed $6.00M.
- 2022-09-30: Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months $16.40M.
| Period end | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months as first filed |
|---|---|---|
| 2026-03-31 | $16.13M 10-Q · filed 2026-05-07 | |
| 2023-12-31 | $8.90M 10-K · filed 2025-03-20 | |
| 2022-12-31 | $5.96M 10-K · filed 2024-03-14 | $6.00M 10-Q · filed 2023-05-09 |
| 2022-09-30 | $16.40M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $27.40M 10-Q · filed 2022-08-08 | |
| 2022-03-31 | $50.90M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $15.80M 10-Q · filed 2022-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |